No profile data available.
Teva Pharmaceutical Industries Limited (TEVA) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Tel Aviv-Yafo, Israel, with about 31,173 full-time employees.
It reported revenue of $17.26 billion for fiscal year 2025, up 4.3% from fiscal year 2024, and net income of $1.41 billion. In Q2 2026 (the quarter ended June 30, 2026) revenue was $4.14 billion, down 0.8% from a year before. Its largest business segment, UNITED STATES, brought in 53% of segment revenue in fiscal year 2025. Its market capitalization was $47.93 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
Teva Pharmaceutical Industries reported $17.26 billion in revenue for fiscal year 2025, up 4.3% from $16.54 billion in fiscal year 2024. In Q2 2026 revenue was $4.14 billion.
UNITED STATES, with $9.19 billion or 53% of segment revenue in fiscal year 2025. Next: Europe (29%) and International Markets (13%).
$47.93 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Sanofi (SNY), GSK plc (GSK), Takeda Pharmaceutical Company Limited (TAK), Haleon plc (HLN).